The survival analysis showed that the CRC patients with low level of the HtrA1 protein (protein level lower or equal to 0.6-fold decrease as compared to control group) had a significantly lower survival rate (45%) than the patients with a high HtrA1 level (79%) (Figure 5A). The gene discussed is HTRA1; the disease is colorectal carcinoma.